References
Anand BS, Romero JJ, et al. Phospholipid
association reduces the gastric mucosal toxicity of aspirin in human
subjects. Am J Gastroenterol. 1999 Jul;94(7):181822.
Ankeer A. Acetaminophen. In: Ford MD et al, eds. Clinical Toxicology. 1st ed. St. Louis, Mo: W. B. Saunders; 2001:26573.
Bandarage UK, Janero DR. Nitric oxide-releasing nonsteroidal
anti-inflammatory drugs: Novel gastrointestinal-sparing drugs. Mini Rev
Med Chem. 2001 May;1(1):5770.
Bartlett D. Acetaminophen toxicity. J Emerg Nurs. 2004 Jun;30(3):2813.
Basaga H, Poli G, et al. Free radical scavenging and antioxidative
properties of silibin complexes on microsomal lipid peroxidation.
Cell Biochem Funct. 1997;15(1):2733.
Becker JC, Domschke W, et al. Current approaches to prevent
NSAID-induced gastropathy--COX selectivity and beyond. Br J Clin
Pharmacol. 2004 Dec;58(6):587-600.
Beers MM et al, eds. The Merck Manual: The Second Home Edition. Whitehouse Station, NJ: Merck Research Laboratories; 2005.
Brestel E. Allergic conditions. In: McClatchey K, ed. Clinical
Laboratory Medicine. Baltimore, Md: Williams & Wilkins; 1994:1643.
Bromer MQ, Black M. Acetaminophen hepatotoxicity. Clin Liver Dis. 2003 May;7(2):35167.
Davila JC, Lenherr A, et al. Protective effect of flavonoids on
drug-induced hepatotoxicity in vitro. Toxicology. 1989;57(3):26786.
Derby LE, Jick H. Acetaminophen and renal and bladder cancer. Epidemiology. 1996 Jul;7(4):35862.
Faintuch J, Aguilar PB, et al. Relevance of N-acetylcysteine in
clinical practice: Fact, myth or consequence? Nutrition. 1999
Feb;15(2):1779.
Flora K, Hahn M, et al. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 1998;93(2):13943.
Ford MD, et al, eds. Clinical Toxicology. 1st ed. St. Louis, Mo: W. B. Saunders; 2001.
Gago-Dominguez M, Yuan JM, et al. Regular use of analgesics is a
risk factor for renal cell carcinoma. Br J Cancer. 1999 Oct;81(3):5428.
Harris Interactive, Inc. Attitudes and Beliefs About the Use of
Over-the-Counter Medications: A Dose of Reality. Available at:
www.bemedwise.org/survey/final_survey.pdf. Accessed September 19, 2005.
Harris RA, Crabb DW. Metabolic interrelationships. In: Devlin TM,
ed. Textbook of Biochemistry with Clinical Correlations. 5th ed. New
York: Wiley-Liss; 2002:86298.
Kaye JA, Myers MW, et al. Acetaminophen and the risk of renal and
bladder cancer in the general practice research database. Epidemiology.
2001 Nov;12(6):6904.
Leyck S, Dereu N, et al. Improvement of the gastric tolerance of
non-steroidal anti-inflammatory drugs by polyene-phosphatidylcholine
(Phospholipon 100). Eur J Pharmacol. 1985 Oct 29;117(1):3542.
Marcus R, Coulston AM. Fat soluble vitamins: Vitamins A, K, and E.
In: Goodman LS, Gilman A, et al, eds. Pharmacological Basis of
Therapeutics. 19th ed. New York: McGraw-Hill; 2001:1773.
Muriel P, Garciapina T, et al. Silymarin protects against
paracetamol-induced lipid peroxidation and liver damage. J Appl
Toxicol. 1992;12(6):43942.
OMalley P. Too much of a good thing: Paracetamol (acetaminophen)
toxicity: Update for the clinical nurse specialist. Clin Nurse Spec.
2005 Jan;19(1):189.
Oz HS, McClain CJ, et al. Diverse antioxidants protect against
acetaminophen hepatotoxicity. J Biochem Mol Toxicol. 2004;18(6):3618.
Peura DA. Gastrointestinal safety and tolerability of nonselective
nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective
inhibitors. Cleve Clin J Med. 2002;69(Suppl 1):SI31SI39.
Roberts LJ II, Morrow JD. Analgesic-antipyretic and antiinflammatory
agents. In: Goodman LS, Gilman A, et al, eds. Pharmacological Basis of
Therapeutics. 19th ed. New York: McGraw-Hill; 2001:687.
Schoenfeld P, Kimmey MB, et al. Review article: nonsteroidal
anti-inflammatory drug-associated gastrointestinal
complications--guidelines for prevention and treatment. Aliment
Pharmacol Ther. 1999 Oct;13(10):1273-85.
Sener G, Sehirli AO, et al. Protective effects of melatonin, vitamin
E and N-acetylcysteine against acetaminophen toxicity in mice: A
comparative study. J Pineal Res. 2003 Aug;35(1):618.
Shear NH, Malkiewicz IM, et al. Acetaminophen-induced toxicity to
human epidermoid cell line A431 and hepatoblastoma cell line Hep G2, in
vitro, is diminished by silymarin. Skin Pharmacol. 1995;8(6):27991.
Whelton A, Hamilton CW. Nonsteroidal anti-inflammatory drugs:
Effects on kidney function. J Clin Pharmacol. 1991 Jul;31(7):58898.
Wu E. Diagnostic enzymology. In: McClatchey K, ed. Clinical
Laboratory Medicine. Baltimore, Md: Williams & Wilkins; 1994:26465.